Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
Free Access to eSymposia On Demand
A key part of our mission at Keystone Symposia is to extend the reach of the latest scientific and medical discoveries to diverse audiences around the globe, so they may benefit all of humanity....
Accelerating Alzheimer’s Disease Research, Diagnostics & Treatments with Collaborative ...
Alzheimer’s disease has proven a very tough nut to crack, and despite decades of research we are still frustratingly far from treating this tragic disease. As our population ages, Alzheimer’s disease is becoming increasingly...
New Frontiers in Tuberculosis Research Dr. Bruno Andrade
In this KSQA feature interview, Dr. Bruno Andrade, co-organizer of the upcoming eSymposia virtual meeting on “Tuberculosis: Science Aimed at Ending the Epidemic,” shares how new technologies and integrative approaches are enabling a deeper...
Editor Reflections: Cell Press’ Catarina Sacristan on Autophagy
The “Autophagy: Mechanisms & Disease” eSymposia brought together the autophagy community from around the world, literally encompassing researchers from 6 continents, 31 countries, and a multitude of timezones, to connect virtually with each other...
Editor Reflections on Vaccinology eSymposia with Nature, Frontiers, JEM & EMBO Journals
Back in July, Keystone Symposia launched our new virtual eSymposia series with the timely “Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats.” The inaugural event garnering global interest from...